Use of serum B‐cell maturation antigen levels to predict outcomes for myeloma patients treated with ruxolitinib, lenalidomide and methylprednisolone
Bujarski, Sean, Sutanto, Christine, Spektor, Tanya M., To, Jennifer, Swift, Regina A., Green, Tracy, Eades, Benjamin R., Emamy‐Sadr, Marsiye, Souther, Eric, Berenson, James R.
Published in Hematological oncology (01.04.2022)
Published in Hematological oncology (01.04.2022)
Get full text
Journal Article